Skip to main content
Erschienen in: Head and Neck Pathology 1/2014

01.03.2014 | Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 2, 2014, San Diego, California

Recently Described Sinonasal Tract Lesions/Neoplasms: Considerations for the New World Health Organization Book

verfasst von: Bruce M. Wenig

Erschienen in: Head and Neck Pathology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Since the publication of the World Health Organization Classification of Head and Neck Tumors (Barnes et al., World Health Organization classification of tumours. Pathology and genetics head and neck tumours, IARC Press, Lyon, pp 10–80, 2001), a number of sinonasal lesions have been more completely described. This manuscript will focus on three such “new” lesions including sero mucinous hamartoma, HPV-related carcinoma with adenoid cystic-like features and low-grade sinonasal sarcoma with neural and myogenic features.
Literatur
1.
Zurück zum Zitat Barnes L, Eveson JW, Reichart P, Sidransky D. Tumours of the nasal cavity and paranasal sinuses. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics head and neck tumours. IARC Press; Lyon: 2005:10–80. Barnes L, Eveson JW, Reichart P, Sidransky D. Tumours of the nasal cavity and paranasal sinuses. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics head and neck tumours. IARC Press; Lyon: 2005:10–80.
2.
Zurück zum Zitat Baillie EE, Batsakis JG. Glandular (seromucinous) hamartoma of the nasopharynx. Oral Surg Oral Med Oral Pathol. 1974;38:760–2.PubMedCrossRef Baillie EE, Batsakis JG. Glandular (seromucinous) hamartoma of the nasopharynx. Oral Surg Oral Med Oral Pathol. 1974;38:760–2.PubMedCrossRef
3.
Zurück zum Zitat Weinreb I, Gnepp DR, Laver NM, et al. Seromucinous hamartomas: a clinicopathological study of a sinonasal glandular lesion lacking myoepithelial cells. Histopathology. 2009;54:205–13.PubMedCrossRef Weinreb I, Gnepp DR, Laver NM, et al. Seromucinous hamartomas: a clinicopathological study of a sinonasal glandular lesion lacking myoepithelial cells. Histopathology. 2009;54:205–13.PubMedCrossRef
4.
Zurück zum Zitat Ambrosini-Spaltro A, Morandi L, Spagnolo DV, et al. Nasal seromucinous hamartoma (microglandular adenosis of the nose): a morphological and molecular study of five cases. Virchows Arch. 2010;457:727–34.PubMedCrossRef Ambrosini-Spaltro A, Morandi L, Spagnolo DV, et al. Nasal seromucinous hamartoma (microglandular adenosis of the nose): a morphological and molecular study of five cases. Virchows Arch. 2010;457:727–34.PubMedCrossRef
5.
Zurück zum Zitat Khan RA, Chernock RD, Lewis JS Jr. Seromucinous hamartoma of the nasal cavity: a report of two cases and review of the literature. Head Neck Pathol. 2011;5(3):241–7.PubMedCentralPubMedCrossRef Khan RA, Chernock RD, Lewis JS Jr. Seromucinous hamartoma of the nasal cavity: a report of two cases and review of the literature. Head Neck Pathol. 2011;5(3):241–7.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Perez-Ordoñez B. Hamartomas, papillomas and adenocarcinomas of the sinonasal tract and nasopharynx. J Clin Pathol. 2009;62:1085–95.PubMedCrossRef Perez-Ordoñez B. Hamartomas, papillomas and adenocarcinomas of the sinonasal tract and nasopharynx. J Clin Pathol. 2009;62:1085–95.PubMedCrossRef
8.
Zurück zum Zitat Fleming KE, Perez-Ordoñez B, Nasser JG, Paooy B, Bullock MJ. Sinonasal seromucinous hamartoma: a review of the literature and a case report with focal myoepithelial cells. Head Neck. 2102;6:395–9.CrossRef Fleming KE, Perez-Ordoñez B, Nasser JG, Paooy B, Bullock MJ. Sinonasal seromucinous hamartoma: a review of the literature and a case report with focal myoepithelial cells. Head Neck. 2102;6:395–9.CrossRef
9.
Zurück zum Zitat Ozolek JA, Hunt JL. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. Am J Surg Pathol. 2006;30:1576–80.PubMedCrossRef Ozolek JA, Hunt JL. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. Am J Surg Pathol. 2006;30:1576–80.PubMedCrossRef
10.
Zurück zum Zitat Ozolek JA, Barnes EL, Hunt JL. Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study. Arch Pathol Lab Med. 2007;131:530–7.PubMed Ozolek JA, Barnes EL, Hunt JL. Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study. Arch Pathol Lab Med. 2007;131:530–7.PubMed
11.
Zurück zum Zitat Wenig BM, Heffner DK. Respiratory epithelial adenomatoid hamartomas of the sinonasal tract and nasopharynx: a clinicopathologic study of 31 cases. Ann Otol Rhinol Laryngol. 1995;104:639–45.PubMed Wenig BM, Heffner DK. Respiratory epithelial adenomatoid hamartomas of the sinonasal tract and nasopharynx: a clinicopathologic study of 31 cases. Ann Otol Rhinol Laryngol. 1995;104:639–45.PubMed
12.
Zurück zum Zitat Bishop JA, Ogawa T, Stelow EB, Moskaluk CA, Koch WM, Westra WH. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal trac. Am J Surg Pathol. 2013;37:836–44.PubMedCrossRef Bishop JA, Ogawa T, Stelow EB, Moskaluk CA, Koch WM, Westra WH. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal trac. Am J Surg Pathol. 2013;37:836–44.PubMedCrossRef
13.
Zurück zum Zitat Lewis JT, Oliveira AM, Nascimento AG, et al. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol. 2012;36:517–25.PubMedCrossRef Lewis JT, Oliveira AM, Nascimento AG, et al. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol. 2012;36:517–25.PubMedCrossRef
14.
Zurück zum Zitat Heffner DK, Gnepp DR. Sinonasal fibrosarcomas, malignant schwannomas, and “Triton” tumors. A clinicopathologic study of 67 cases. Cancer. 1992;70:1089–101.PubMedCrossRef Heffner DK, Gnepp DR. Sinonasal fibrosarcomas, malignant schwannomas, and “Triton” tumors. A clinicopathologic study of 67 cases. Cancer. 1992;70:1089–101.PubMedCrossRef
Metadaten
Titel
Recently Described Sinonasal Tract Lesions/Neoplasms: Considerations for the New World Health Organization Book
verfasst von
Bruce M. Wenig
Publikationsdatum
01.03.2014
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2014
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-014-0533-9

Weitere Artikel der Ausgabe 1/2014

Head and Neck Pathology 1/2014 Zur Ausgabe

Sine qua non Radiology-Pathology

Bilateral Laryngoceles

Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 2, 2014, San Diego, California

Neuroendocrine Neoplasms of the Head and Neck: Some Suggestions for the New WHO Classification of Head and Neck Tumors

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …